21 CFR Part 660 · Additional Standards for Diagnostic Substances for Laboratory Tests

§ 660.30 Reagent Red Blood Cells

Subpart D - Reagent Red Blood Cells Official text on eCFR Amendment history

(a) Proper name and definition. The proper name of the product shall be Reagent Red Blood Cells, which shall consist of a preparation of human red blood cells used to detect or identify human blood-group antibodies.

(b) Source. Reagent Red Blood Cells shall be prepared from human peripheral blood meeting the criteria of §§ 660.31 and 660.32 of this chapter , or from umbilical cord cells which shall be collected and prepared according to the manufacturer's biologics license application.

Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.

Amendment history

Federal Register documents that created or amended this section.